Result Summary for 113377
| Protocol ID: | 113377 |
| Clinical Study ID: | AC4113377 |
| Official Title: | Phase I study of GSK573719 -A randomized, double blind, placebo controlled, dose ascending, single and repeat dose study to investigate the safety, tolerability, and pharmacokinetics of inhaled dose of GSK573719 from a novel dry powder device in healthy Japanese male subjects - |
| Phase: | phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | umeclidinium bromide |
| Trade/Product Name: | umeclidinium bromide |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
